BioFlyte
- Company typePrivate
- Founded2020
- HeadquartersAlbuquerque, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
BioFlyte firmographics
Firmographics- Name
- BioFlyte
- Legal name
- BioFlyte, Inc.
- Website
- https://bioflyte.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
BioFlyte industry classification
Industry- Product category
- Biothreat Detection Equipment
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- akta.pro primary industry
- Air & Aerosol Monitoring (Bioaerosols, Mold, Yeast, Airborne Pathogens) (AFALAEAD)
Keywords
Where BioFlyte is headquartered
LocationHeadquarters
- HQ city
- Albuquerque
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BioFlyte business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Hardware Systems Sales: Sale of BioTOF z200 bioaerosol identifier systems and MailScreen z200 mailroom workstations for threat detection in critical infrastructure and mail screening applications.
- Maintenance and Support Services: Ongoing system maintenance, cloud-based software updates, threat library updates, and quarterly preventative maintenance services.
- Consumables: Replacement consumables including sample disks and microliter solvent mixtures consumed during each test cycle.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Enterprise hardware and deployment |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
BioFlyte product offering
Product offeringCore offering
BioFlyte develops, manufactures, and sells fieldable aerosol mass spectrometers (BioTOF z200) and integrated mail-screening workstations (MailScreen z200) that automatically collect and analyze air and mail samples for biological and chemical threats. The company commercializes MALDI-TOF mass spectrometry adapted from clinical laboratory settings for autonomous deployment at airports, government facilities, mailrooms, and other critical infrastructure sites.
Product overview
BioFlyte offers two integrated products: the BioTOF™ z200 as the core platform (a fieldable MALDI time-of-flight mass spectrometer with autonomous aerosol collection and AI/ML threat identification), and the MailScreen™ z200 as a specialized add-on workstation (a mailroom threat detection solution powered by the BioTOF z200 system with a dedicated Command Console interface). The products share underlying BioTOF mass spectrometry and AI/ML technology but serve different market segments—BioTOF for continuous environmental monitoring in critical infrastructure, and MailScreen for batch mail/parcel screening in mail processing facilities.
Differentiator
Problem solved
Functional benefit
Products and services
- BioTOF z200 Bioaerosol Identifier A fieldable MALDI time-of-flight mass spectrometer with integrated robotics and AI/ML algorithms that automatically collects and analyzes aerosol samples for bacteria, viruses, biotoxins (anthrax, ricin), and pharmaceutical-based chemical threats such as fentanyl. Designed for continuous autonomous operation at airports, government facilities, arenas, and commercial buildings, with approximately 5-minute collection-to-alarm detection.
- MailScreen z200 Mailroom Workstation A mailroom workstation powered by BioTOF z200 technology that safely identifies hazardous biological powders and chemical threats in mail and parcels. Includes a Windows-based tablet Command Console for system operation, status display, and results communication, providing an all-hazards solution for mailroom risk management.
- Maintenance, Support, and Threat Library Services Ongoing managed services covering system maintenance, cloud-based software and threat library updates, quarterly preventative maintenance, and consumable replenishment (sample disks and solvent mixtures) for installed BioTOF and MailScreen deployments.
Quantifiable outcome
- 5-minute detection from collection to alarm
- +5 more outcomes
Companies that use BioFlyte
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
BioFlyte technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature6 records
BioFlyte partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core, major and minor.
- Los Alamos National LaboratorycoreCollaboration under New Mexico Technology Readiness Gross Receipts (TRGR) initiative to optimize modeling and simulation tools for biothreat detection. Project enhances indoor aerosol modeling capabilities using LANL's QUIC software.
- SoBran Inc.majorStrategic collaboration where SoBran utilizes BioTOF z200 for SafeMail screening services across the United States. SoBran protects government clients, Fortune 500 companies, and major universities from mail-borne attacks.
- Avarint, LLCminorThird-party validation testing partner for aerosolized fentanyl detection capabilities. Conducted independent testing with pure fentanyl and fentanyl mixed with cutting agents.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
BioFlyte competitors and assessment
Company assessmentDirect peers
- Bruker Corporation: Bruker owns the underlying MALDI-TOF mass spectrometry technology category that BioFlyte adapted for field deployment. Bruker's clinical MALDI Biotyper is widely deployed in laboratories, making it the most direct comparable from a technology and product standpoint.
- Rapiscan Systems (OSI Systems): Provides mail and parcel screening systems for government and enterprise customers, including biological threat detection. Competes with MailScreen z200 in the same mail security vertical.
- MSA Security: Provides mail and package screening services for corporations, government agencies, and institutions, including biological threat detection. Competes with BioFlyte in the mail security services vertical where BioFlyte partners with SoBran.
- Smiths Detection: Global leader in threat detection and screening technologies for airports, mailrooms, and critical infrastructure, including biological and chemical agent detection systems. Directly competes with BioTOF in mail screening and aviation security markets.
Emerging players
- Bertin Technologies: European CBRN defense equipment manufacturer offering biological agent detection and identification systems. Emerging player with overlapping product capabilities in biodefense detection.
- Pendar Sciences: Developer of portable Raman spectroscopy systems for chemical and explosive detection at point-of-need. Emerging player with adjacent fieldable detection technology applicable to security and defense markets.
Broad incumbents
- Agilent Technologies: Major analytical laboratory instrument manufacturer with mass spectrometry and chromatography products used in security and forensic applications. Broad incumbent that could enter BioFlyte's niche with adapted technology.
- Thermo Fisher Scientific: Largest analytical instrument manufacturer globally, including MALDI-TOF mass spectrometry products for clinical diagnostics. A potential competitive threat if Thermo Fisher extends its mass spec portfolio to fieldable biodefense applications.
- Battelle Memorial Institute: Major nonprofit biodefense research and systems integrator with deep DoD and DHS relationships. Competes for biodefense contracts and offers broader CBRN defense solutions than BioFlyte's focused approach.
- Teledyne FLIR: Provides a broad portfolio of chemical, biological, and radiological detection systems primarily for military and homeland security applications. Overlaps with BioFlyte in defense and public safety verticals but offers a much wider product portfolio.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
BioFlyte social profiles
Digital presenceBioFlyte compliance and trust
Trust signalCompliance1 record
BioFlyte financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioFlyte leadership team
Management profileNumber of profiles
Profiles18 records
BioFlyte funding detail
Funding detailFunding overview
Funding rounds4 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioFlyte M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioFlyte
What does BioFlyte do?
BioFlyte develops, manufactures, and sells fieldable aerosol mass spectrometers (BioTOF z200) and integrated mail-screening workstations (MailScreen z200) that automatically collect and analyze air and mail samples for biological and chemical threats. The company commercializes MALDI-TOF mass spectrometry adapted from clinical laboratory settings for autonomous deployment at airports, government facilities, mailrooms, and other critical infrastructure sites.
Is BioFlyte a public or private company?
BioFlyte is a private company. It is classified as venture growth investor backed and is currently operating.
When was BioFlyte founded?
BioFlyte was founded in 2020. It employs 11 to 50 people.
Where is BioFlyte based?
BioFlyte is headquartered in Albuquerque, United States, in the North America region.
How does BioFlyte make money?
Three revenue lines are on record. Hardware Systems Sales are the primary driver. The others are maintenance and Support Services and consumables.
Who are BioFlyte's main competitors?
Direct peers on record are Bruker Corporation, Rapiscan Systems (OSI Systems), MSA Security and Smiths Detection. Emerging players are Bertin Technologies and Pendar Sciences. Broad incumbents are Agilent Technologies, Thermo Fisher Scientific, Battelle Memorial Institute and Teledyne FLIR.
Does BioFlyte have an API?
No public API is recorded for BioFlyte.
What industry is BioFlyte in?
BioFlyte's product category is Biothreat Detection Equipment. Its primary akta.pro industry code is AFALAEAD, Air & Aerosol Monitoring (Bioaerosols, Mold, Yeast, Airborne Pathogens). Its NAICS code is 334516.